SCHEMBL845203

SCHEMBL845203

CCN(CC)C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)N(CC)CC)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.47
PABPC1 P11940 1/20 0.47
ALDH1A1 P00352 3/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
NPC1 O15118 1/20 0.46
LMNA P02545 3/20 0.45
GAA P10253 1/20 0.45
KDM4E B2RXH2 1/20 0.45
HTT P42858 2/20 0.45
MAPK1 P28482 2/20 0.45
POLB P06746 1/20 0.44
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845774 0.87 CYP2C19 (0.49) PABPC1ALDH1A1CYP2C9CYP2C19NPC1
SCHEMBL845202 0.86 CYP2C19 (0.48) PABPC1ALDH1A1CYP2C9CYP2C19NPC1
SCHEMBL845488 0.86 CYP2C19 (0.48) PABPC1ALDH1A1CYP2C9CYP2C19NPC1
SCHEMBL845759 0.86 CYP2C19 (0.48) PABPC1ALDH1A1CYP2C9CYP2C19NPC1
SCHEMBL845251 0.84 PABPC1 (0.50) PABPC1ALDH1A1CYP2C9CYP2C19NPC1
SCHEMBL844902 0.84 ALDH1A1 (0.47) CCR1PABPC1ALDH1A1CYP2C9CYP2C19
SCHEMBL845295 0.82 KDM4E (0.61) PABPC1ALDH1A1CYP2C9CYP2C19NPC1
SCHEMBL844894 0.82 CYP2C19 (0.55) ALDH1A1CYP2C9CYP2C19NPC1LMNA
SCHEMBL844890 0.82 KCNH2 (0.51) PABPC1ALDH1A1CYP2C9CYP2C19NPC1
SCHEMBL845245 0.81 PTPN1 (0.50) PABPC1ALDH1A1CYP2C9CYP2C19NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed